We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
1801
DELISTED
Diebold Nixdorf Incorporated
DBD
| $7.05M | ﹤0.01% |
667,748
-46,383
| -6% | -$412K |
|
1802
PRA Group
PRAA
$755M
| $7.04M | ﹤0.01% |
194,010
-1,987
| -1% | -$70.4K |
|
1803
Theravance Biopharma
TBPH
$877M
| $7.04M | ﹤0.01% |
271,951
-5,840
| -2% | -$113K |
|
1804
SAP
SAP
$238B
| $7.02M | ﹤0.01% |
52,425
-1,774
| -3% | -$233K |
|
|
KREF
1805
KKR Real Estate Finance Trust
KREF
$499M
| $7.02M | ﹤0.01% |
343,854
-526,741
| -61% | -$10.5M |
|
1806
Nelnet
NNI
$4.7B
| $7.02M | ﹤0.01% |
120,555
-2,234
| -2% | -$137K |
|
1807
Lindblad Expeditions
LIND
$2.22B
| $7.01M | ﹤0.01% |
428,785
+1,614
| +0.4% | +$25.8K |
|
1808
Powell Industries
POWL
$7.71B
| $6.99M | ﹤0.01% |
428,028
+138,792
| +48% | +$1.95M |
|
1809
Shake Shack
SHAK
$2.87B
| $6.98M | ﹤0.01% |
117,101
-1,442
| -1% | -$104K |
|
1810
First Citizens BancShares
FCNCA
$25.3B
| $6.97M | ﹤0.01% |
13,099
-8,495
| -39% | -$4.3M |
|
1811
Gentherm
THRM
$1.27B
| $6.96M | ﹤0.01% |
156,830
+7,965
| +5% | +$339K |
|
1812
BOK Financial
BOKF
$8.74B
| $6.96M | ﹤0.01% |
79,592
+266
| +0.3% | +$21.7K |
|
1813
JELD-WEN Holding
JELD
$164M
| $6.95M | ﹤0.01% |
297,016
-9,826
| -3% | -$202K |
|
1814
Universal Electronics
UEIC
$61.3M
| $6.93M | ﹤0.01% |
132,691
-7,518
| -5% | -$403K |
|
|
ODP
1815
DELISTED
ODP
ODP
| $6.91M | ﹤0.01% |
252,343
-8,208
| -3% | -$183K |
|
1816
ICU Medical
ICUI
$4.61B
| $6.9M | ﹤0.01% |
36,859
-4,529
| -11% | -$779K |
|
1817
Green Dot
GDOT
$745M
| $6.86M | ﹤0.01% |
294,508
+649
| +0.2% | +$16.2K |
|
|
TCDA
1818
DELISTED
Tricida, Inc. Common Stock
TCDA
| $6.85M | ﹤0.01% |
181,413
+77,920
| +75% | +$2.9M |
|
|
HMHC
1819
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $6.83M | ﹤0.01% |
1,093,368
-276,820
| -20% | -$1.62M |
|
1820
Cheesecake Factory
CAKE
$5.33B
| $6.82M | ﹤0.01% |
175,561
-1,444
| -0.8% | -$59.5K |
|
1821
ePlus
PLUS
$2.34B
| $6.82M | ﹤0.01% |
161,792
+56,306
| +53% | +$2.29M |
|
1822
AppFolio
APPF
$7.04B
| $6.81M | ﹤0.01% |
61,962
+5,319
| +9% | +$542K |
|
1823
Enel Chile
ENIC
$6.28B
| $6.8M | ﹤0.01% |
1,432,437
-304,801
| -18% | -$1.32M |
|
|
CATM
1824
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $6.8M | ﹤0.01% |
152,302
-7,121
| -4% | -$270K |
|
1825
Columbia Sportswear
COLM
$2.94B
| $6.8M | ﹤0.01% |
67,853
-44,348
| -40% | -$4.21M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.